Target- |
MechanismImmunostimulants |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date29 Jul 2011 |
Target- |
MechanismImmunostimulants |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date27 Nov 1995 |
Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date13 Mar 1924 |
100 Clinical Results associated with Nielsen Bioscience, Inc
0 Patents (Medical) associated with Nielsen Bioscience, Inc
100 Deals associated with Nielsen Bioscience, Inc
100 Translational Medicine associated with Nielsen Bioscience, Inc